日本ANCA血管炎队列肾脏预后评分开发
INTRODUCTION: Glomerulonephritis is frequent in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) and crucial to disease outcomes.…
要点
- MCCS和ARRS对日本ANCA肾炎患者ESKD风险的预测能力得到验证。
- 新评分PACS基于四种肾小球病变百分比构建,预测ESKD性能与ARRS相当。
- PACS预测60个月ESKD风险的最佳截断值为43%。
核心结论
- 基于日本ANCA肾炎患者肾活检病理数据开发的新评分PACS可预测肾脏预后,预测ESKD性能与ARRS相当。
主要发现
- MCCS和ARRS对ESKD风险的预测能力得到确认。
- 细胞性、纤维细胞性、纤维性新月体及硬化肾小球百分比具有显著ESKD风险预测能力。
- PACS预测ESKD的ROC曲线下面积为0.783。
- PACS预测60个月ESKD风险的最佳截断值为43%。
- 细胞性新月体百分比和间质炎症是肾功能恢复的独立预测因素。
关键数值与推荐
- PACS评分基于细胞性、纤维细胞性、纤维性新月体及硬化肾小球占总肾小球的百分比。
- PACS预测ESKD的ROC曲线下面积为0.783。
- PACS预测60个月ESKD风险的最佳截断值为43%。
临床怎么用
- PACS可用于日本ANCA肾炎患者的肾脏预后评估,指导临床决策。
局限性
- 结果需在国际队列中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Glomerulonephritis is frequent in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) and crucial to disease outcomes. We conducted a detailed assessment of renal pathology in Japanese patients with AAV, and developed a new score that would predict renal outcome. METHODS: Two hundred twenty-one patients who were diagnosed with AAV and underwent a kidney biopsy were enrolled. Data on glomerular, tubular, interstitial, and vascular lesions from kidney biopsies were analyzed; the 3 established classification and prognostic scoring systems (Berden Classification, Mayo Clinic/RPS Chronicity Score [MCCS], and ANCA Renal Risk Score [ARRS]) were validated. Further, we developed a new prognostic score by including variables relevant for Japanese patients with ANCA-glomerulonephritis. RESULTS: Median follow-up was 60 months (interquartile range: 6-60). End-stage kidney disease (ESKD) risk prediction by the MCCS and the ARRS was confirmed. Moreover, our analysis identified 4 items with significant ESKD risk prediction capacity, namely percentage of cellular, fibrocellular, and fibrous crescents; and sclerotic glomeruli. Based on our findings, we created a score evaluating the percentage of these lesions to total glomeruli, the Percentage of ANCA Crescentic Score (PACS). The area under the receiver operating characteristic (ROC) curve evaluating PACS was 0.783. The PACS had a comparable performance as the ARRS in predicting ESKD. The optimal PACS cut-off for ESKD risk over 60 months was 43%. In addition, the percentage of cellular crescents and presence of interstitial inflammation were independent predictors of kidney function recovery. CONCLUSION: We developed a new score predicting renal prognosis using histopathological data of Japanese patients with ANCA-glomerulonephritis. Studies are needed to validate our results in international cohorts.
引用
- Takeda R, Takahashi K, Kronbichler A, et al. Development of a Kidney Prognostic Score in a Japanese Cohort of Patients With Antineutrophil Cytoplasmic Autoantibody Vasculitis. Kidney Int Rep. 2024. PMID: 38481514. doi:10.1016/j.ekir.2024.01.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。